(Total Views: 639)
Posted On: 10/16/2020 8:46:35 PM
Post# of 148932
Not sure what this means, but it sure sounds good. I stole it from yahoo finance comments on CYDY>
To clarify 'pathway'
'Management will discuss the recommendations of the Data Safety Monitoring Committee (DSMC) following their review of the interim analysis of the first 195 patients enrolled in the Company’s Phase 2b/3 clinical trial for patients with severe-to-critical COVID-19 indications, including a potential regulatory path forward.'
This means DSMC has recommended they submit a NDA (New Drug Application) to the FDA under
pathway 505 b 1, new drug. Safety, effectiveness, and manufacturing efficiency are looked at and when met
LL will be approved for marketing.
...and subsequent moon launches etc...will take place
$$$$$$$$$$$$$$$$$$$$$$$$$$$$>>>>>>>>>>>
Less
To clarify 'pathway'
'Management will discuss the recommendations of the Data Safety Monitoring Committee (DSMC) following their review of the interim analysis of the first 195 patients enrolled in the Company’s Phase 2b/3 clinical trial for patients with severe-to-critical COVID-19 indications, including a potential regulatory path forward.'
This means DSMC has recommended they submit a NDA (New Drug Application) to the FDA under
pathway 505 b 1, new drug. Safety, effectiveness, and manufacturing efficiency are looked at and when met
LL will be approved for marketing.
...and subsequent moon launches etc...will take place
$$$$$$$$$$$$$$$$$$$$$$$$$$$$>>>>>>>>>>> Less
(4)
(0)Scroll down for more posts ▼
